WELCOME TO BIOSION

Biosion is a clinical-stage biotechnology company committed to developing breakthrough antibody-based therapies to improve patient outcomes for the treatment of immune and oncologic diseases. Established in 2017, Biosion has built a pipeline of innovative biologics through its internally derived proprietary technologies including the H³ antibody discovery platform, SynTracer® high-throughput endocytosis platform, and Flexibody® bispecific platform. Biosion's lead asset, BSI-045B (anti-TSLP mAb), is currently in phase-II for severe asthma and atopic dermatitis, with 4 other assets in the clinic with our partners. Biosion has operations in the US, Australia and China. For more information, please visit www.biosion.com.

COMPANY CULTURE

  • Mission

    To discover and develop innovative biologics through the synergy of great science, cutting edge technologies and superior craftsmanship for patients worldwide

    Mission

    To discover and develop innovative biologics through the synergy of great science, cutting edge technologies and superior craftsmanship for patients worldwide

  • Vision

    To deliver breakthrough therapeutics to patients globally

    Vision

    To deliver breakthrough therapeutics to patients globally

  • Culture

    Patients ∙ Employee ∙ Society ∙ Synergy ∙ Adeptness ∙ Integrity

    Culture

    Patients ∙ Employee ∙ Society ∙ Synergy ∙ Adeptness ∙ Integrity

EXECUTIVE TEAM
  • Timothy P. Coogan, Ph.D., DABT
  • Mingjiu Chen, Ph.D.
    Founder, Chairman and CEO
  • Lei Zheng, MD, Ph.D.
    Advisory Board Chair
  • Helen Han Hsu, DVM, Ph.D.
  • Hugh M. Davis, Ph.D.
    Chief Business and Development Officer & President, Biosion USA
  • Qi Liu, MD, Ph.D.
  • Uma Prabhakar, Ph.D.
  • Jonathan Silverberg, M.D., Ph.D.
  • Amy Jennings, Ph.D.
  • Anthony Yeh, Ph.D.
    Chief Strategy Officer & Head of China BD
  • Steven Knapp，Pharm.D.
    Chief Regulatory and Quality Officer
  • Tariq Ghayur, Ph.D.
  • Donald Heald, Ph.D.
  • Helena Zhang, MD, MBA,
    Head of Global Clinical Development
  • Rakesh Dixit, Ph.D., DABT
  • Aaron Weitzman, MD
  • T. Shantha Raju, Ph.D.
  • Mark Ma, Ph.D.
    Head of Discovery Engine
  • Nando Bansal, Ph.D.
  • Anderson Zhang, MBA
    Head of Finance
DEVELOPMENT TEAM
  • Timothy P. Coogan, Ph.D., DABT
  • Mingjiu Chen, Ph.D.
    Founder, Chairman and CEO
  • Lei Zheng, MD, Ph.D.
    Advisory Board Chair
  • Helen Han Hsu, DVM, Ph.D.
  • Hugh M. Davis, Ph.D.
    Chief Business and Development Officer & President, Biosion USA
  • Qi Liu, MD, Ph.D.
  • Uma Prabhakar, Ph.D.
  • Jonathan Silverberg, M.D., Ph.D.
  • Amy Jennings, Ph.D.
  • Anthony Yeh, Ph.D.
    Chief Strategy Officer & Head of China BD
  • Steven Knapp，Pharm.D.
    Chief Regulatory and Quality Officer
  • Tariq Ghayur, Ph.D.
  • Donald Heald, Ph.D.
  • Helena Zhang, MD, MBA,
    Head of Global Clinical Development
  • Rakesh Dixit, Ph.D., DABT
  • Aaron Weitzman, MD
  • T. Shantha Raju, Ph.D.
  • Mark Ma, Ph.D.
    Head of Discovery Engine
  • Nando Bansal, Ph.D.
  • Anderson Zhang, MBA
    Head of Finance
ADVISORY BOARD
  • Timothy P. Coogan, Ph.D., DABT
  • Mingjiu Chen, Ph.D.
    Founder, Chairman and CEO
  • Lei Zheng, MD, Ph.D.
    Advisory Board Chair
  • Helen Han Hsu, DVM, Ph.D.
  • Hugh M. Davis, Ph.D.
    Chief Business and Development Officer & President, Biosion USA
  • Qi Liu, MD, Ph.D.
  • Uma Prabhakar, Ph.D.
  • Jonathan Silverberg, M.D., Ph.D.
  • Amy Jennings, Ph.D.
  • Anthony Yeh, Ph.D.
    Chief Strategy Officer & Head of China BD
  • Steven Knapp，Pharm.D.
    Chief Regulatory and Quality Officer
  • Tariq Ghayur, Ph.D.
  • Donald Heald, Ph.D.
  • Helena Zhang, MD, MBA,
    Head of Global Clinical Development
  • Rakesh Dixit, Ph.D., DABT
  • Aaron Weitzman, MD
  • T. Shantha Raju, Ph.D.
  • Mark Ma, Ph.D.
    Head of Discovery Engine
  • Nando Bansal, Ph.D.
  • Anderson Zhang, MBA
    Head of Finance
CONTACT

Biosion Australia Pty Ltd

Early Clinical Development

Biosion Australia

58 Gipps Street Collingwood, Victoria 3066 Australia

Tel：1-302-998-5126

Email：BD@Biosion.com

Biosion, Inc.

China Business Development and Clinical Hub

Biosion China - Shanghai

Global Discovery and Development Center

Biosion China - Nanjing （HQ）

Building D, Zhongdan Unit, Nanjing Jiangbei New Area, China 210061

Tel：86-25-5829-1977

Fax：86-25-8650-7191

Email：BD@Biosion.com

Biosion USA, Inc.

Global Business Development Hub

Biosion USA - SoCal

Global Clinical Development Hub

Biosion USA - Philadelphia

1 Innovation Way, Suite 300, Newark, Delaware 19711, USA

Tel：1-302-998-5126

Email：BD@Biosion.com

Email Us
Biosion’s Mission
To discover and develop innovative biologics through the synergy of great science, cutting edge technologies and superior craftsmanship for patients worldwide
Biosion USA, Inc. 1 Innovation Way, Suite 300, Newark, Delaware 19711, USA
BD@Biosion.com
1-302-998-5126
Copyright © 2022. Biosion All rights reserved. 苏ICP备2022027163号
BIOSION’s Mission
To discover and develop innovative biologics through the synergy of great science, cutting edge technologies and superior craftsmanship for patients worldwide
Biosion USA, Inc. 1 Innovation Way, Suite 300, Newark, Delaware 19711, USA
BD@Biosion.com
1-302-998-5126
Copyright © 2022. Biosion All rights reserved. 苏ICP备2022027163号
WELCOME TO BIOSION
Biosion is a clinical-stage biotechnology company committed to developing breakthrough antibody-based therapies to improve patient outcomes for the treatment of immune and oncologic diseases. Established in 2017, Biosion has built a pipeline of innovative biologics through its internally derived proprietary technologies including the H³ antibody discovery platform, SynTracer® high-throughput endocytosis platform, and Flexibody® bispecific platform. Biosion's lead asset, BSI-045B (anti-TSLP mAb), is currently in phase-II for severe asthma and atopic dermatitis, with 4 other assets in the clinic with our partners. Biosion has operations in the US, Australia and China. For more information, please visit www.biosion.com.
COMPANY CULTURE
EXECUTIVE TEAM
  • Timothy P. Coogan, Ph.D., DABT
  • Mingjiu Chen, Ph.D.
    Founder, Chairman and CEO
  • Lei Zheng, MD, Ph.D.
    Advisory Board Chair
  • Helen Han Hsu, DVM, Ph.D.
  • Hugh M. Davis, Ph.D.
    Chief Business and Development Officer & President, Biosion USA
  • Qi Liu, MD, Ph.D.
  • Uma Prabhakar, Ph.D.
  • Jonathan Silverberg, M.D., Ph.D.
  • Amy Jennings, Ph.D.
  • Anthony Yeh, Ph.D.
    Chief Strategy Officer & Head of China BD
  • Steven Knapp，Pharm.D.
    Chief Regulatory and Quality Officer
  • Tariq Ghayur, Ph.D.
  • Donald Heald, Ph.D.
  • Helena Zhang, MD, MBA,
    Head of Global Clinical Development
  • Rakesh Dixit, Ph.D., DABT
  • Aaron Weitzman, MD
  • T. Shantha Raju, Ph.D.
  • Mark Ma, Ph.D.
    Head of Discovery Engine
  • Nando Bansal, Ph.D.
  • Anderson Zhang, MBA
    Head of Finance
DEVELOPMENT TEAM
  • Timothy P. Coogan, Ph.D., DABT
  • Mingjiu Chen, Ph.D.
    Founder, Chairman and CEO
  • Lei Zheng, MD, Ph.D.
    Advisory Board Chair
  • Helen Han Hsu, DVM, Ph.D.
  • Hugh M. Davis, Ph.D.
    Chief Business and Development Officer & President, Biosion USA
  • Qi Liu, MD, Ph.D.
  • Uma Prabhakar, Ph.D.
  • Jonathan Silverberg, M.D., Ph.D.
  • Amy Jennings, Ph.D.
  • Anthony Yeh, Ph.D.
    Chief Strategy Officer & Head of China BD
  • Steven Knapp，Pharm.D.
    Chief Regulatory and Quality Officer
  • Tariq Ghayur, Ph.D.
  • Donald Heald, Ph.D.
  • Helena Zhang, MD, MBA,
    Head of Global Clinical Development
  • Rakesh Dixit, Ph.D., DABT
  • Aaron Weitzman, MD
  • T. Shantha Raju, Ph.D.
  • Mark Ma, Ph.D.
    Head of Discovery Engine
  • Nando Bansal, Ph.D.
  • Anderson Zhang, MBA
    Head of Finance
ADVISORY BOARD
  • Timothy P. Coogan, Ph.D., DABT
  • Mingjiu Chen, Ph.D.
    Founder, Chairman and CEO
  • Lei Zheng, MD, Ph.D.
    Advisory Board Chair
  • Helen Han Hsu, DVM, Ph.D.
  • Hugh M. Davis, Ph.D.
    Chief Business and Development Officer & President, Biosion USA
  • Qi Liu, MD, Ph.D.
  • Uma Prabhakar, Ph.D.
  • Jonathan Silverberg, M.D., Ph.D.
  • Amy Jennings, Ph.D.
  • Anthony Yeh, Ph.D.
    Chief Strategy Officer & Head of China BD
  • Steven Knapp，Pharm.D.
    Chief Regulatory and Quality Officer
  • Tariq Ghayur, Ph.D.
  • Donald Heald, Ph.D.
  • Helena Zhang, MD, MBA,
    Head of Global Clinical Development
  • Rakesh Dixit, Ph.D., DABT
  • Aaron Weitzman, MD
  • T. Shantha Raju, Ph.D.
  • Mark Ma, Ph.D.
    Head of Discovery Engine
  • Nando Bansal, Ph.D.
  • Anderson Zhang, MBA
    Head of Finance
CONTACT
Biosion Australia Pty Ltd

Early Clinical Development

Biosion Australia

58 Gipps Street Collingwood, Victoria 3066 Australia

Tel：1-302-998-5126

Fax：BD@Biosion.com

Email：BD@Biosion.com

Biosion, Inc.

China Business Development and Clinical Hub

Biosion China - Shanghai

Global Discovery and Development Center

Biosion China - Nanjing （HQ）

Building D, Zhongdan Unit, Nanjing Jiangbei New Area, China 210061

Tel：86-25-5829-1977

Fax：BD@Biosion.com

Email：BD@Biosion.com

Biosion USA, Inc.

Global Business Development Hub

Biosion USA - SoCal

Global Clinical Development Hub

Biosion USA - Philadelphia

1 Innovation Way, Suite 300, Newark, Delaware 19711, USA

Tel：1-302-998-5126

Fax：BD@Biosion.com

Email：BD@Biosion.com

Biosion’s Mission
To discover and develop innovative biologics through the synergy of great science, cutting edge technologies and superior craftsmanship for patients worldwide
Biosion USA, Inc. 1 Innovation Way, Suite 300, Newark, Delaware 19711, USA
BD@Biosion.com
1-302-998-5126
Copyright © 2022. Biosion All rights reserved. 苏ICP备2022027163号
BIOSION’s Mission
To discover and develop innovative biologics through the synergy of great science, cutting edge technologies and superior craftsmanship for patients worldwide
Biosion USA, Inc. 1 Innovation Way, Suite 300, Newark, Delaware 19711, USA
BD@Biosion.com
1-302-998-5126
Copyright © 2022. Biosion All rights reserved. 苏ICP备2022027163号